Growth modulation index (GMI) as a comparative measure of clinical activity of larotrectinib versus prior systemic treatments in adult and pediatric TRK fusion cancer patients Meeting Abstract
| Authors: | Italiano, A.; Nanda, S.; Keating, K.; Childs, B. H.; Fellous, M.; Drilon, A.; Hyman, D. M. |
| Abstract Title: | Growth modulation index (GMI) as a comparative measure of clinical activity of larotrectinib versus prior systemic treatments in adult and pediatric TRK fusion cancer patients |
| Meeting Title: | 44th ESMO Congress (ESMO 2019) |
| Journal Title: | Annals of Oncology |
| Volume: | 30 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2019 Sep 27-Oct 1 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2019-10-01 |
| Start Page: | mdz244.047 |
| Language: | English |
| ACCESSION: | WOS:000491295501302 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdz244.047 |
| Notes: | Meeting Abstract: 485P -- Appears on pages v183-v184 of the abstract book -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
